Plant-Produced Recombinant Humaninterleukin-2
Print
EmailRecombinant human interleukin-2 (rhIL-2) is a biopharmaceutical protein of great importance, asit is the standard FDA-approved immunotherapeutic treatment for end-stage metastatic melanomaand renal cell cancer.
Find out more about this topic in this article.
Did you find this article useful?
You Might Also Be Interested In
-
CANR student Ashley Prince talks with the Class of 2021 about resilience, empowerment and growth.
Published on May 18, 2021
-
MSU School of Packaging alum helping with COVID-19 therapeutics and vaccines
Published on February 4, 2021
-
Kelly Millenbah recommended as CANR interim dean
Published on May 10, 2021
-
MSU leaders share new diversity directions in higher education and Extension
Published on July 20, 2021
